A Study to Collect Data to Build Artificial Intelligence Derived Algorithms for Estimating Iron Status of Children
Launched by DANONE ASIA PACIFIC HOLDINGS PTE, LTD. · Aug 27, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to gather information to help create smarter tools that can better estimate iron levels in children. Iron is an essential nutrient, and not having enough can lead to health problems, particularly in young kids. The study is currently recruiting participants, specifically children aged between 6 months and 6 years. To participate, parents must be at least 21 years old, have access to the internet, and be comfortable with their child undergoing a blood test.
If you decide to take part, you and your child will fill out some questionnaires online, which will help researchers gather important data. It's important to note that some children may not be eligible for the study, especially those with certain medical conditions or issues that might affect how their blood can be tested. Overall, this trial aims to improve how we assess iron levels in young children, which can lead to better health outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Children above 6 months of age and below 6 years of age
- • 2. Written consent from parent(s) or legally acceptable representative(s), who themselves are aged ≥ 21 years old, to consent and comply with the terms and conditions of the study
- • 3. Parent(s) should have access to the internet and a smartphone or tablet to complete study questionnaires
- • 4. Parent(s) should be able to comprehend the content of the study and complete the study questionnaires
- • 5. Parents(s) must be comfortable with their child having blood draws
- • 6. Subject has a Hb level corresponding to a Hb group with open slots for participation
- Exclusion Criteria:
- • 1. Children with any medical condition that in the opinion of the investigator would not be suitable for enrolment.
- • 2. Children with nail bed obstructions, nail polish, nails discolouration (e.g., leukonychia, melanonychia, bruising, etc.), or scarring of the lips, pigmentations on lips for thyroid dysfunction (e.g., Puettz-jeghers syndrome).
- • 3. Children who are unable to cooperate with study procedures.
- • 4. Employees and/or children/family members or relatives of employees of Danone Global Research \& Innovation Center or the participating sites.
About Danone Asia Pacific Holdings Pte, Ltd.
Danone Asia Pacific Holdings Pte, Ltd. is a leading global health-focused food company dedicated to delivering innovative nutritional solutions that promote health and well-being. As a subsidiary of Danone, a multinational corporation with a strong commitment to sustainability and social responsibility, the company operates in diverse markets across the Asia Pacific region. Danone Asia Pacific Holdings Pte, Ltd. actively engages in clinical trials to evaluate the efficacy and safety of its products, aiming to contribute to scientific research and improve health outcomes for consumers. Through its rigorous research initiatives, the company underscores its dedication to advancing knowledge in nutrition and fostering healthier communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Khon Kaen, , Thailand
Singapore, , Singapore
Patients applied
Trial Officials
Poh Choo Dr Khoo
Principal Investigator
KK Women's and Children's Hospital
Assoc.Prof. Suchaorn Saengnipanthkul
Principal Investigator
Srinagarind Hospital, Khon Kaen University, Khon Kaen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported